117 related articles for article (PubMed ID: 31842153)
1. Does Early Chemotherapy Improve Survival in Advanced Endometrial Cancer?: Erratum.
Am J Clin Oncol; 2020 Jan; 43(1):71. PubMed ID: 31842153
[No Abstract] [Full Text] [Related]
2. Does Early Chemotherapy Improve Survival in Advanced Endometrial Cancer?
Boothe D; Orton A; Kim J; Poppe MM; Werner TL; Gaffney DK
Am J Clin Oncol; 2019 Nov; 42(11):813-817. PubMed ID: 31592805
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant chemotherapy in endometrial carcinoma: overview of randomised trials.
Hogberg T
Clin Oncol (R Coll Radiol); 2008 Aug; 20(6):463-9. PubMed ID: 18467080
[TBL] [Abstract][Full Text] [Related]
4. [Preliminary study of sequential multi-modality adjuvant chemotherapy and radiation for advanced endometrial cancer].
Zhang G; Suo HY; Shen XY; Zhao LJ; Wang ZQ; Kong WM; Li XP; Wang JL; Wei LH
Zhonghua Fu Chan Ke Za Zhi; 2019 Feb; 54(2):103-109. PubMed ID: 30803169
[No Abstract] [Full Text] [Related]
5. Chemotherapy for advanced endometrial cancer with carboplatin and epirubicin.
Tirmazy SH; Barthakur U; El-Modir A; Anwar S; Fernando I
Anticancer Res; 2014 Jul; 34(7):3793-8. PubMed ID: 24982404
[TBL] [Abstract][Full Text] [Related]
6. The benefit of adjuvant chemotherapy combined with postoperative radiotherapy for endometrial cancer: a meta-analysis.
Park HJ; Nam EJ; Kim S; Kim YB; Kim YT
Eur J Obstet Gynecol Reprod Biol; 2013 Sep; 170(1):39-44. PubMed ID: 23810000
[TBL] [Abstract][Full Text] [Related]
7. A multicenter evaluation of sequential multimodality therapy and clinical outcome for the treatment of advanced endometrial cancer.
Secord AA; Havrilesky LJ; O'Malley DM; Bae-Jump V; Fleming ND; Broadwater G; Cohn DE; Gehrig PA
Gynecol Oncol; 2009 Sep; 114(3):442-7. PubMed ID: 19560193
[TBL] [Abstract][Full Text] [Related]
8. The role of multi-modality adjuvant chemotherapy and radiation in women with advanced stage endometrial cancer.
Alvarez Secord A; Havrilesky LJ; Bae-Jump V; Chin J; Calingaert B; Bland A; Rutledge TL; Berchuck A; Clarke-Pearson DL; Gehrig PA
Gynecol Oncol; 2007 Nov; 107(2):285-91. PubMed ID: 17688923
[TBL] [Abstract][Full Text] [Related]
9. Systemic therapy for the treatment of endometrial cancer.
Neri M; Peiretti M; Melis GB; Piras B; Vallerino V; Paoletti AM; Madeddu C; Scartozzi M; Mais V
Expert Opin Pharmacother; 2019 Nov; 20(16):2019-2032. PubMed ID: 31451034
[No Abstract] [Full Text] [Related]
10. What's new in systemic therapy for endometrial cancer.
Kieser K; Oza AM
Curr Opin Oncol; 2005 Sep; 17(5):500-4. PubMed ID: 16093803
[TBL] [Abstract][Full Text] [Related]
11. The assessment of overall survival (OS) after adjuvant chemotherapy for patients with malignant endometrial cancer in Poland.
Teter Z; Śliwczyński A; Brzozowska M; Świerkowski M; Jacyna A; Pinkas J; Sierocka A; Marczak M; Dańska-Bidzińska A; Bidziński M; Wierzba W
Ginekol Pol; 2017; 88(6):296-301. PubMed ID: 28727127
[TBL] [Abstract][Full Text] [Related]
12. Systemic therapy in metastatic or recurrent endometrial cancer.
Pectasides D; Pectasides E; Economopoulos T
Cancer Treat Rev; 2007 Apr; 33(2):177-90. PubMed ID: 17196749
[TBL] [Abstract][Full Text] [Related]
13. Neoadjuvant chemotherapy in patients with advanced endometrial cancer.
Khouri OR; Frey MK; Musa F; Muggia F; Lee J; Boyd L; Curtin JP; Pothuri B
Cancer Chemother Pharmacol; 2019 Aug; 84(2):281-285. PubMed ID: 30980132
[TBL] [Abstract][Full Text] [Related]
14. Chemotherapy for high-risk early-stage endometrial cancer.
Kodama J; Seki N; Hiramatsu Y
Curr Opin Obstet Gynecol; 2007 Feb; 19(1):42-7. PubMed ID: 17218851
[TBL] [Abstract][Full Text] [Related]
15. Chemotherapy plus radiation in advanced-stage endometrial cancer.
Schwandt A; Chen WC; Martra F; Zola P; Debernardo R; Kunos CA
Int J Gynecol Cancer; 2011 Dec; 21(9):1622-7. PubMed ID: 21897269
[TBL] [Abstract][Full Text] [Related]
16. [Chemotherapy of uterine endometrial cancer].
Hayakawa S; Sato S; Takano T; Wagazuma S; Yajima A
Gan To Kagaku Ryoho; 1995 Aug; 22(9):1169-75. PubMed ID: 7661568
[TBL] [Abstract][Full Text] [Related]
17. A phase II trial of irinotecan in patients with advanced or recurrent endometrial cancer and correlation with biomarker analysis.
Nishio S; Shimokawa M; Tasaki K; Nasu H; Yoshimitsu T; Matsukuma K; Terada A; Tsuda N; Kawano K; Ushijima K
Gynecol Oncol; 2018 Sep; 150(3):432-437. PubMed ID: 30037491
[TBL] [Abstract][Full Text] [Related]
18. Improving survival after endometrial cancer: the big picture.
Kwon JS
J Gynecol Oncol; 2015 Jul; 26(3):227-31. PubMed ID: 26197859
[TBL] [Abstract][Full Text] [Related]
19. Randomized evidence on chemotherapy and hormonal therapy regimens for advanced endometrial cancer: an overview of survival data.
Polyzos NP; Pavlidis N; Paraskevaidis E; Ioannidis JP
Eur J Cancer; 2006 Feb; 42(3):319-26. PubMed ID: 16376072
[TBL] [Abstract][Full Text] [Related]
20. Old and new perspectives in the pharmacological treatment of advanced or recurrent endometrial cancer: Hormonal therapy, chemotherapy and molecularly targeted therapies.
Gadducci A; Cosio S; Genazzani AR
Crit Rev Oncol Hematol; 2006 Jun; 58(3):242-56. PubMed ID: 16436330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
